Search

Search Results
Results 4601 - 4610 of 4638 for multiple sclerosis
  • Enbrel
    Drug - 16 May 2024
    Consumer Medicine Information (CMI) about Enbrel intended for persons living in Australia.
  • Afinitor
    Drug - 21 Mar 2024
    Consumer Medicine Information (CMI) about Afinitor intended for persons living in Australia.
  • Lioresal Intrathecal
    Drug - 26 Feb 2024
    Consumer Medicine Information (CMI) about Lioresal Intrathecal intended for persons living in Australia.
  • Lozanoc
    Drug - 8 Feb 2024
    Consumer Medicine Information (CMI) about Lozanoc intended for persons living in Australia.
  • Coversyl
    Drug - 8 Feb 2024
    Consumer Medicine Information (CMI) about Coversyl intended for persons living in Australia.
  • Rapamune Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Tablets intended for persons living in Australia.
  • Rapamune Oral Solution
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Oral Solution intended for persons living in Australia.
  • Xigduo XR
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Xigduo XR intended for persons living in Australia.
  • Kombiglyze XR
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Kombiglyze XR intended for persons living in Australia.
  • Understanding the evolution of antibody affinity maturation and humanization
    White Paper - 29 May 2023
    In this article, Sino Biological discusses the evolution of antibody humanization and affinity maturation and how this affects the life sciences field.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback